Samsung Biologics (KRX:207940), a South Korea-based contract development and manufacturing organisation (CDMO), said on Thursday that it received recognition at the 2026 CDMO Leadership Awards presented by Outsourced Pharma and Life Science Connect.

The company was awarded the Sustainability Leadership Award, a jury-selected distinction recognising efforts to advance sustainable practices across its operations and value chain. Samsung Biologics was also named 'Best in Class' in Cultural Fit in the 'Biologics--Large CDMOs' category.

The CDMO Leadership Awards aim to recognise top-performing development and manufacturing service providers based on global client feedback across areas such as facilities, innovation, technical expertise, and manufacturing capabilities.